Literature DB >> 7691513

Drug effects on the electrocardiogram. A review of their clinical importance.

J D Symanski1, L S Gettes.   

Abstract

It is clear that many patients are now being treated with multiple pharmacological agents which may alter membrane function and ionic fluxes across membranes. Therefore, these agents will frequently influence the electrical behavioural of all excitable tissues including the myocardial cell. The changes in the myocardial cell are often reflected by changes, some subtle, some obvious, on the body surface electrocardiogram. Thus, the electrocardiogram provides the physician with a reasonably simple and inexpensive tool for monitoring drug effects and for detecting changes that may be toxic and/or life-threatening. For this reason, an appreciation of these changes by the noncardiologist has become increasingly important.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691513     DOI: 10.2165/00003495-199346020-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  215 in total

1.  The electrocardiogram in acute arsenic poisoning.

Authors:  S L WEINBERG
Journal:  Am Heart J       Date:  1960-12       Impact factor: 4.749

Review 2.  Electrophysiologic substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations?

Authors:  B Surawicz
Journal:  J Am Coll Cardiol       Date:  1989-07       Impact factor: 24.094

3.  Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs.

Authors:  N O Fowler; D McCall; T C Chou; J C Holmes; I B Hanenson
Journal:  Am J Cardiol       Date:  1976-02       Impact factor: 2.778

Review 4.  Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil.

Authors:  M R Rosen; A L Wit; B F Hoffman
Journal:  Am Heart J       Date:  1975-05       Impact factor: 4.749

5.  Use-dependent effects of amiodarone on Vmax in cardiac Purkinje and ventricular muscle fibers.

Authors:  A Varro; Y Nakaya; V Elharrar; B Surawicz
Journal:  Eur J Pharmacol       Date:  1985-06-19       Impact factor: 4.432

6.  Cardiovascular manifestations of tricyclic antidepressant overdose.

Authors:  R A Langou; C Van Dyke; S R Tahan; L S Cohen
Journal:  Am Heart J       Date:  1980-10       Impact factor: 4.749

7.  Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias.

Authors:  J P diMarco; T D Sellers; B B Lerman; M L Greenberg; R M Berne; L Belardinelli
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

8.  Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone.

Authors:  J W Mason; L M Hondeghem; B G Katzung
Journal:  Circ Res       Date:  1984-09       Impact factor: 17.367

9.  Intravenous amiodarone in the acute treatment of recurrent symptomatic ventricular tachycardia.

Authors:  F Morady; M M Scheinman; E Shen; W Shapiro; R J Sung; L DiCarlo
Journal:  Am J Cardiol       Date:  1983-01-01       Impact factor: 2.778

10.  Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers.

Authors:  N Ikeda; B N Singh; L D Davis; O Hauswirth
Journal:  J Am Coll Cardiol       Date:  1985-02       Impact factor: 24.094

View more
  4 in total

Review 1.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

2.  Use of 24 h ambulatory ECG recordings in the assessment of new chemical entities in healthy volunteers.

Authors:  J C Stinson; J S Pears; A J Williams; R W Campbell
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

3.  Designing and interpreting the results of first-time-to-man studies.

Authors:  A A Patat
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

Review 4.  Molecular and cellular mechanisms of cardiotoxicity.

Authors:  Y J Kang
Journal:  Environ Health Perspect       Date:  2001-03       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.